(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -205.71%-637.15K | -12.10%-214.65K | 70.77%-27.94K | 247.90%831.25K | 1,242.95%1.33M | 32.05%-208.42K | -422.95%-191.49K | 6.82%-95.61K | -157.87%-562.02K | -14.87%-116.08K |
Net income from continuing operations | -0.17%-251.28K | -85.78%-329.19K | 11.33%-119.5K | 253.78%818.61K | 1,306.54%1.38M | -33.35%-250.86K | -12.10%-177.2K | -88.12%-134.77K | -141.35%-532.33K | 2.65%-114.5K |
Operating gains losses | ---- | ---- | ---- | ---1.9K | ---- | ---- | ---- | ---- | ---- | ---- |
Remuneration paid in stock | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Change In working capital | -1,009.17%-385.87K | -145.92%-35.14K | 133.76%91.56K | 149.00%14.55K | -140.59%-52.77K | 135.79%42.44K | -110.08%-14.29K | 226.49%39.17K | -1,235.37%-29.69K | -232.43%-21.94K |
-Change in prepaid assets | -1,602.12%-402K | --0 | -54.35%12.18K | 141.42%12.5K | 23.89%-14.18K | 3,562.10%26.76K | -642.15%-26.76K | 472.10%26.67K | ---30.17K | ---18.63K |
-Change in payables and accrued expense | 2.86%16.13K | -317.64%-35.14K | 799.94%79.38K | -20.60%2.05K | -1,066.10%-38.6K | 113.31%15.68K | -88.90%16.15K | 140.65%8.82K | -13.90%2.58K | -115.35%-3.31K |
-Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 275.00%3.68K | -446.88%-2.1K | --0 |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -205.71%-637.15K | -12.10%-214.65K | 70.77%-27.94K | 247.90%831.25K | 1,242.95%1.33M | 32.05%-208.42K | -422.95%-191.49K | 6.82%-95.61K | -157.87%-562.02K | -14.87%-116.08K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -53.34K | -311.97K | -117.86K | 201.63%118.92K | 118.92K | 0 | 0 | 0 | -117.02K | 0 |
Net PPE purchase and sale | ---53.34K | ---311.97K | ---117.86K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net other investing changes | ---- | ---- | ---- | 201.63%118.92K | ---- | ---- | ---- | ---- | ---117.02K | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---53.34K | ---311.97K | ---117.86K | 201.63%118.92K | --118.92K | --0 | --0 | --0 | ---117.02K | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 0 | 1.04M | -8.21K | ||||||
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --1.04M | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --1.04M | ---8.21K |
Net cash flow | ||||||||||
Beginning cash position | 156.34%926.16K | 162.81%1.45M | 146.54%1.6M | 122.60%648.4K | -80.21%152.89K | 555.02%361.31K | 192.98%552.8K | 122.60%648.4K | -42.80%291.28K | 96.95%772.69K |
Current changes in cash | 103.18%6.63K | -175.01%-526.62K | -52.50%-145.8K | 166.07%950.17K | 1,263.14%1.45M | -129.05%-208.42K | -43.42%-191.49K | 6.82%-95.61K | 263.86%357.12K | -23.00%-124.29K |
End cash Position | 510.10%932.78K | 156.34%926.16K | 162.81%1.45M | 146.54%1.6M | 146.54%1.6M | -80.21%152.89K | 555.02%361.31K | 192.98%552.8K | 122.60%648.4K | 122.60%648.4K |
Free cash from | -231.30%-690.49K | -175.01%-526.62K | -52.50%-145.8K | 247.90%831.25K | 1,242.95%1.33M | 32.05%-208.42K | -422.95%-191.49K | 6.82%-95.61K | -157.87%-562.02K | -14.87%-116.08K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data